Titan Pharmaceuticals
TTNP
#10414
Rank
โ‚น0.55 B
Marketcap
โ‚น414.15
Share price
-3.76%
Change (1 day)
30.44%
Change (1 year)

Revenue for Titan Pharmaceuticals (TTNP)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of โ‚น0.08 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Titan Pharmaceuticals from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A-100%
2023 โ‚น0.08 M-98.35%
2022 โ‚น5.04 M-72.76%
2021 โ‚น18.53 M67.83%
2020 โ‚น11.04 M-88.28%
2019 โ‚น94.2 M-77.21%
2018 โ‚น0.41 B2911.25%
2017 โ‚น13.72 M-98.66%
2016 โ‚น1.02 B821.9%
2015 โ‚น0.11 B-51.93%
2014 โ‚น0.23 B-64.32%
2013 โ‚น0.64 B66.17%
2012 โ‚น0.38 B81.08%
2011 โ‚น0.21 B-52.42%
2010 โ‚น0.45 B12238.15%
2009 โ‚น3.66 M
2006 โ‚น1.41 M-64.61%
2005 โ‚น4 M
2002 โ‚น0.13 B-37.13%
2001 โ‚น0.22 B151.42%
2000 โ‚น87.74 M479.98%
1999 โ‚น15.12 M18.6%
1998 โ‚น12.75 M-98.17%
1997 โ‚น0.69 B3769.87%
1996 โ‚น17.97 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Vanda Pharmaceuticals
VNDA
โ‚น19.05 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
โ‚น12.09 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚น0.23 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น8.278 TN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น5.064 TN/A๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Repligen
RGEN
โ‚น63.59 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA